SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Markets: XCRT) and Dr. Dilan Ellegala Xcelerate Advisory Board Member Discussing the Launch of a Pilot Program in Tanzania
Xcelerate, Inc. (OTC Pink: XCRT) has initiated a pilot program in partnership with AfiyaSasa Africa, LLC to enhance healthcare delivery in Tanzania using AI and augmented reality. The company's 51% stake in ASA aims to address the shortage of medical professionals identified by Dr. Dilan Ellegala, who highlighted there were merely two neurosurgeons for 44 million people in the region. This innovative approach seeks to leverage advanced technology to improve medical services. More details can be found in the interview conducted by SmallCapVoice.com.
- Initiation of a pilot program in Tanzania aimed at improving healthcare delivery.
- Strategic partnership with AfiyaSasa Africa leveraging AI and AR technology.
- Addressing significant healthcare gaps identified in Tanzania.
- Concerns regarding the continuity and experience of newly implemented technologies.
- Potential operational challenges in the pilot program affecting scalability.
AUSTIN, Texas, April 04, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Pink: XCRT), and Dr. Dilan Ellegala, a member of the Company’s advisory board and co-founder of AfiyaSasa Africa, LLC ("ASA").
ASA is a medical technology and virtual health company positioned to use artificial intelligence (“AI”) and augmented reality (“AR”) to help meet the needs of patients in developing countries. Through Xcelerate’s
Speaking with SCV’s Stuart Smith, Dr. Ellegala explains how, during his time in Africa over a decade ago, he identified a massive discrepancy in the number of physicians available for the population. “In my specialty of neurosurgery at the time, there were two neurosurgeons for 44 million people. … the reality is that we could spend 10, 20, 30, 50 years building hospitals clinics, trying to develop health care professionals, spending hundreds of millions, maybe billions of dollars and we probably still wouldn't meet the basic needs of the population. What I realized is that we needed to leverage the power of advanced technology to try and bridge that gap. It has taken 15-16 years and … we're finally able, I think, to do this,” he says.
The interview further highlights the application of AI to fill this need, along with Xcelerate’s patent-pending medical surgical device and the Company’s near-term goals.
The full interview can be viewed at https://www.smallcapvoice.com/april-interview-xcelerate-xcrt/.
About SmallCapVoice.com
SmallCapVoice.com, Inc. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies, small cap and micro-cap stocks build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, podcasts, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks in which they are interested. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTCMarkets. To learn more about SmallCapVoice.com and its services, please visit https://www.smallcapvoice.com/small-cap-stock-otc-investor-relations-financial-public-relations/.
Socialize with SmallCapVoice and their clients at
Facebook: https://www.facebook.com/SmallCapVoice/
Twitter: https://twitter.com/smallcapvoice
Instagram: https://www.instagram.com/smallcapvoice/
Forward-Looking Statements
This news release contains forward-looking statements that reflect Management's current views about future events and financial performance. Forward-looking statements often contain words such as ''expects,'' ''anticipates,'' ''intends,'' or ''believes.'' Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact Information:
Xcelerate Inc.
www.Xcelerate.Global
854-900-2020
Mike@Xcelerate.Global
SmallCapVoice.com
Stuart T. Smith
512-267-2430
Info@SmallCapVoice.com
Source: SmallCapVoice.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d5f51ac2-be1f-485b-9c2a-884653477e60
FAQ
What is the significance of Xcelerate's pilot program in Tanzania?
Who are the key figures involved in the Xcelerate press release?
When was the pilot program in Tanzania announced?
What technology is being used in Xcelerate's healthcare initiatives?
What issue does Dr. Ellegala's statement address?
